A. Leyva et al., Oncocalyxones A and C, 1,4-anthracenediones from auxemma oncocalyx: Comparison with anticancer 1,9-anthracenediones, ANTICANC R, 20(2A), 2000, pp. 1029-1031
Oncocalyxones A and C are 1,4-anthracenediones isolated fi om Auxemma oncoc
alyx (Boraginaceae) that have been shown to be cytotoxic to tumor cells in
vitro. The present study compared the cytotoxicity of these compounds with
that of two conventional anticancer agents doxorubicin and mitoxantrone, bo
th 1,9-anthmcenediones, in a panel of human. tumor cell lines. The effect o
n cell growth was examined using an MTT microtiter assay in two leukemia li
nes, five solid tumor fines of different histological origin, and two multi
drug-resistant sublines of a lung tumor line. The oncocalyxones showed much
lower potency than the 1,9-anthracenediones, but were similarly more cytot
oxic to leukemia cells compared to solid tumor lines. However; in the multi
drug-resistant cells with 10 to 500 times decreased sensitivity to doxorubi
cin, the cytotoxicity of oncacalyxones A and C was only modestly reduced by
about twofold. 1,4-Anthracenediones may be a promising novel class of chem
otherapeutic agents effective against multidrug resistant tumors.